Multivitamin Recall Update for 25 States As FDA Sets Risk Level
A chewable multivitamin distributed across 25 states has been recalled after federal inspectors found the product contained lower‑than‑intended…
FDA under scrutiny: 4 issues facing beleaguered agency
The U.S. Food and Drug Administration (FDA) has faced an unusual convergence of political, scientific, legal and operational…
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug…
Top FDA drug official is trying to hire a friend who’s seeking a bold new warning on antidepressants
WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
FDA sends warning to 30 telehealth companies selling ‘illegal’ GLP-1s
The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales…
Eli Lilly on track to launch oral obesity drug in second quarter, pending US approval
March 2 (Reuters) – Eli Lilly CFO Lucas Montarce said on Monday it is preparing to launch its…
FDA to offer bonus payments to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA accepts BMS protein degrader for review; Disc rare disease drug rejected
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Doctors Warn: Common Daily Supplement Mistake Could Harm Your Health
About 75% of Americans take some kind of supplement regularly, making it a common practice in the U.S.…
Disc Medicine to pursue traditional U.S. approval after FDA rejects new fast-track route
Feb 17 (Reuters) – Disc Medicine said on Tuesday it will pursue a traditional U.S. approval pathway for…